To overcome this resistance, the addition of an AGR2 blocking antibody to the culture media sensitized resistant tumour cells to chemotherapeutic treatment, suggesting that targeting eAGR2 within the tumour microenvironment might represent a promising strategy to overcome chemotherapy resistance. The gene discussed is AGR2; the disease is neoplasm.